KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy-Reference-Cited by-同舟云学术

KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy

Published:2013-03-16 Issue:5 Volume:133 Page:1259-1265
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Valtorta Emanuele¹,Misale Sandra,Sartore-Bianchi Andrea²,Nagtegaal Iris D.³,Paraf François⁴,Lauricella Calogero¹,Dimartino Valentina⁵,Hobor Sebastijan⁶,Jacobs Bart⁷,Ercolani Cristiana⁵,Lamba Simona,Scala Elisa,Veronese Silvio¹,Laurent-Puig Pierre⁸,Siena Salvatore²,Tejpar Sabine⁷,Mottolese Marcella⁵,Punt Cornelis J.A.⁹,Gambacorta Marcello¹,Bardelli Alberto,Di Nicolantonio Federica

Affiliation:

1. Division of Pathology; Ospedale Niguarda Ca' Granda; Piazza Ospedale Maggiore 3; Milano; Italy

2. The Falck Division of Medical Oncology; Ospedale Niguarda Ca' Granda; Piazza Ospedale Maggiore 3; Milano; Italy

3. Department of Pathology; Radboud University Nijmegen Medical Centre; Nijmegen; The Netherlands

4. Department of Pathology; Dupuytre University Hospital Center; 2 Avenue Martin-Luther-King; Limoges; France

5. Regina Elena Cancer Institute; Pathology Department; Via Elio Chianesi 53; Rome; Italy

6. Department of Oncology; University of Torino; Candiolo (Torino); Italy

7. Laboratory of Molecular Digestive Oncology, Department of Oncology; KU Leuven, Herestraat 49; Leuven; Belgium

8. Paris Sorbonne Cité University; INSERM UMR-S775; 45 Rue des Saints Pères; Paris; France

9. Department of Medical Oncology; Academic Medical Centre; University of Amsterdam; Amsterdam; The Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008

2. Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer;Bardelli;J Clin Oncol,2010

3. K-ras mutations and benefit from cetuximab in advanced colorectal cancer;Karapetis;N Engl J Med,2008

4. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer;Siena;J Natl Cancer I,2009

5. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis;Roock;Lancet Oncol,2010

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of KRAS Gene and microRNA-124-3p in Sporadic Colorectal Tumours;Journal of Biosciences and Medicines;2024

2. An integrated model for predicting KRAS dependency;PLOS Computational Biology;2023-05-04

3. Mechano‐cytoskeleton remodeling mechanism and molecular docking studies on nanosurface technology: Titania nanotube arrays;Biotechnology and Applied Biochemistry;2023-01-05

4. Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023

5. Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity;Cancers;2022-10-12